Clinical Trial

A Study of Single Dose of LP-003 in Adolescent Subjects

Active, Not Recruiting Phase 1/2
View on ClinicalTrials.gov →
Record status
This record was last updated February 17, 2026 (before its estimated May 31, 2026 completion). Its status may not reflect the trial's current state.
Summary
This is a single-center, open-label, phase Ib clinical study to evaluate the safety, pharmacokinetics and pharmacodynamic characteristics of LP-003 injection in adolescent subjects aged 12-18 years.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-08-22.
Status change: Not Yet Recruiting → Active, Not Recruiting 2026-02-12
Trial Details
NCT Number NCT07148557
Lead Sponsor Longbio Pharma
Conditions Allergic Diseases
Enrollment 6 participants
Start Date 2025-10-01
Primary Completion 2026-05-31 (estimated)
Study Completion 2026-09-30 (estimated)
Updated on ClinicalTrials.gov 2026-02-17